Psoriasis Uncovered

Hear the facts about this controversial and rapidly evolving topic, medical use of cannabis-based products for chronic pain with dermatologist Dr. Jason Hawkes, Assistant Professor of Dermatology at the University of California, Davis. Listen to Dr. Hawkes discussion about key components, actions, effects, interactions and how it relates to chronic pain in psoriatic disease.

Listen as pulmonologist, Dr. Albert Rizzo, Chief Medical Officer at the American Lung Association and member of Christiana Care Pulmonary Associates in Newark, DE, and Deb Brown, Chief Mission Officer with the American Lung Association, discuss the relationship between lung health, systemic inflammation and psoriasis. This episode also includes a free special offer for our listeners from the American Lung Association! Listen to learn more about this free offer!

Take action during Psoriasis Action Month by learning why it's important to participate in the PsoProtectMe global survey. Hear from Professor Catherine Smith, Professor of Dermatology and Therapeutics and Consultant Dermatologist, and Dr. Satveer Mahil, a Consultant Dermatologist, from St. John's Institute of Dermatology, Kings College London, about how this survey can advance our understanding of COVID-19 and other factors that impact the management of psoriasis and psoriatic arthritis.

With COVID-19 telehealth became more prevalent in use and with this pivot came challenges and benefits. Hear dermatologist Dr. George Han, System Medical Director for Dermatology at Mount Sinai Health System and Chief of Teledermatology at Icahn School of Medicine at Mount Sinai, discuss the challenges and tips for making telehealth visits with psoriatic disease a successful experience. This Psound Bytes activity is supported by charitable contributions from Amgen, Janssen Pharmaceutical Companies of Johnson and Johnson, and Novartis.

Dr. Kenneth Gordon, a leading dermatologist and expert in psoriasis treatment, shares insights on oral agents for managing psoriasis. He discusses the factors influencing patients' choices for oral medications, highlighting the efficacy of treatments like methotrexate and apremilast. The conversation delves into cyclosporine's rapid effectiveness and the promise of newer options like tofacitinib. Dr. Gordon also offers an optimistic view on future non-biologic therapies, including fumaric acid esters, which are gaining traction in Europe.

The world as we know is changing daily and so did the traditional NPF Capitol Hill Day. Learn about the policies we supported to improve access to care for the psoriatic disease community and how easy it is to advocate from home. To learn more and join our efforts visit advocate.psoriasis.org.

Curious about what triggers psoriatic disease and what to do about flare management? Listen as Dr. Arianne Shadi Kourosh, Assistant Professor of Dermatology at Harvard Medical School and Dr. Theodore Stern, Chief of the Avery D. Weisman, Psychiatry Consultation Services and Professor of Psychiatry at Harvard Medical School, address the physical and emotional triggers that can flare psoriasis and psoriatic arthritis and what you can do to overcome this causality effect. This Psound Bytes activity is supported by a charitable contribution from Janssen Pharmaceutical Companies of Johnson & Johnson.

Nail psoriasis affects up to 55 percent of people with psoriasis and it's tough to treat. Hear why it's difficult to treat and what options are available for managing nail psoriasis from leading dermatologist and NPF Medical Board member, Dr. April Armstrong, Director of the Psoriasis Program, Department of Dermatology at Keck School of Medicine, University of Southern California. This activity is supported by grant funding from AbbVie, Amgen and Lilly.

Hear what factors are considered beyond joint pain and location of psoriasis plaques when exploring a diagnosis of psoriatic arthritis from renowned rheumatologist and NPF Board Member, Dr. Elaine Husni, Vice Chair of the Department of Rheumatic and Immunologic Disease and Director of the Arthritis and Musculoskeletal Center at the Cleveland Clinic. Psoriatic Arthritis Action Month is supported by educational grant funding from AbbVie, Amgen, Bristol Myers Squibb, Lilly, Novartis and Pfizer.

Did you know psoriatic arthritis has six domains that represent musculoskeletal symptoms of the disease? Hear what those domains are along with how coordinated care such as "PPACMAN" can be of benefit to you from leading rheumatologist and NPF Medical Board Member, Dr. Evan Siegel with Arthritis and Rheumatism Associates in Rockville, MD. Psoriatic Arthritis Action Month is supported by educational grant funding from AbbVie, Amgen, Bristol Myers Squibb, Lilly, Novartis and Pfizer.